跳至主要内容
临床试验/IRCT2014010816143N1
IRCT2014010816143N1已完成未知

Double blind randomized placebo-control trial of Allium ampeloprasum cream effect for the management of hemorrhoids symptoms

Shiraz University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • •inclusion criteria:
  • •1- Age: 18 Years to 65 Years
  • •2- Participants who agree to participate in the current study
  • •3- Participants having symptomatic hemorrhoids(GRADE 1-4) without need to emergency operation according to physical examination
  • •4- Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period.
  • •exclusion criteria:
  • •1- Participants having anal fissure or inflammatory bowel disease or history of gastrointestinal cancer
  • •2- Participants having hypersensitive predisposition or hypersensitive to Allium ampeloprasum or history of skin hypersensivity
  • •3- Female participants under pregnancy or during breastfeeding period
  • •4- Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or neurologic disorders or ascitis
  • •g- history of steroid or anticoagulant drug consumption

排除标准

  • 未提供

研究者

相似试验

Evaluation of Allium ampeloprasum cream effect for... | 临床试验